Manuel Antonio Rengel Aranda-rekin lankidetzan egindako argitalpenak (7)

2010

  1. Results of renal re-transplant in Spain (1990-2002)

    NDT Plus, Vol. 3, Núm. SUPPLL. 2

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32

  2. Use of Mycophenolate Sodium in Stable Renal Transplant Recipients in Spain: Preliminary Results of the MIDATA Study

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2309-2312

2007

  1. Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2157-2159

2006

  1. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain

    Clinical Transplantation, Vol. 20, Núm. 5, pp. 650-658

2001

  1. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 121-124

1994

  1. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: A multicenter randomized study

    Transplantation Proceedings